🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The challenges of CAR-T therapies in T-cell lymphoma by Jasmine Zain - Shreevikaa Kannan MedNewsWeek oncodaily.com/blog/136122 #Cancer #Lymphoma #OncoDaily #Oncology #MedNewsWeek

A wonderful milestone CELLebration of treating 1600+ IEC/CAR T patients at City of Hope. Humble to work with so many fabulous staff, colleagues and leaders. Edward S. Kim, MD, MBA, FACP, FASCO Marcel van den Brink City of Hope

Amazing collaborations in this successful National Cancer Institute study led by Dr. Herrera. SWOG Cancer Research Network ECOG-ACRIN Cancer Research Group Children’s Oncology Group CCTG Alliance for Clinical Trials in Oncology Inclusive study enrolling pts aged 12+ with remarkable efficacy across all analyzed subgroups. Best-ever reported US results. nejm.org/doi/full/10.10…

Watch our interview with Craig Portell of UVA Cancer Center to learn about the evolving treatment landscape in the first line for #MantleCellLymphoma and the complexities associated with selecting an appropriate therapy for patients: 🎥 ow.ly/fgFa50TIKOJ #LYMsm #SOHO2024

I’ve survived #myeloma 27 years, thanks to dozens of myeloma experts. Saturday I married dear Karen. Between us we have 97 years of marriage and 45 years of caregiving for our deceased spouses. Advocating for others makes life fulfilling. Enjoy every day God gives you.

Join us in 1 month for a special session preceding the American Society of Hematology (ASH) annual meeting, moderated by Dr. Neil Love, where we'll explore current questions and controversies in the management of hematologic cancers. bit.ly/4fcN2JK

🙌 ICYMI: Kerry Rogers, of The James, discusses the debate at #SOHO2024 on whether BTK inhibitors can be discontinued in #CLL. 📺 Watch here for highlights! buff.ly/3ZLLGAV

Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia | New England Journal of Medicine nejm.org/doi/full/10.10…

Colton Ladbury, MD is working with our City of Hope | Orange County team to strengthen the Gyn, heme, and brachytherapy service lines and doing a great job! We are so fortunate to offer these expert services to help our patients! Joshua Garrett Cohen Seth Cohen

We're thrilled to help make dreams a reality—check us out tomorrow during the Super Bowl! 🏈

doximity.com/newsfeed/7dbfd…

CONGRESS | #EHA2025 | PRESENTATION Bijal D. Shah, Moffitt Cancer Center, presents age-stratified post hoc analysis outcomes of obe-cel in R/R B-ALL from the phase Ib/II FELIX study (N = 127). Outcomes in patients aged <55 yrs, ≥55 yrs, ≥26 yrs, ≥65 yrs were: ORR: 72.2%, 87.5%,

And its the end of #EHA2025. 1st European Congress I made it to the podium. Will never forget the experience! I hope I can do it again and that more people from Latam will be invited. Afterall, European Hematology Association is no longer european, but a Global Association. Grazie Milano!

COALITION is online Journal of Clinical Oncology - an IIT and the FIRST bispecific #glofitamab First Line trial to target very high risk #DLBCL #lymphoma in younger pts. Great work from Adrian Minson and thanks to investigators and teams across Oz. #18ICML #lymsm and thanks to Peter Mac Cancer Centre

As the incoming Chair of the Lymphoma Research Foundation’s Scientific Advisory Board, Andrew M. Evens, DO, MBA, MSc (Rutgers Cancer Institute) is shaping the future of lymphoma treatment, ensuring accessible, cutting-edge care for patients across all demographics: lymphoma.org/news/andrew-ev…

Just dropped: the 3rd ed. Handbook of Hematologic Malignancies! 🚀 Honored to co-edit with David Sallman, Ateefa Chaudhury & Ling Zhang—huge thanks to our 40+ expert authors. Grab it 👉 a.co/d/2svpeyg #Hematology #Oncology #BloodCancer #Lymphoma #Leukemia #MedEd

Fresh from #ICML2025 💜 Prof Jessica Okosun outlines key #FollicularLymphoma findings: - Tafasitamab + R2 gets FDA approval - ELARA confirms CAR T long-term impact - Bispecific antibodies advance globally Full report on our scientific learnings coming soon!

Petros Grivas is Receiving 2025 Young Investigator Award Petros Grivas 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 Fred Hutch Cancer Center oncodaily.com/blog/petros-gr… #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews CancerWorld

Great time today Great Debates in LA. Always enjoyable to discuss MCL with John P. Leonard, MD and even better with a great showing from others City of Hope.

The real value of events like Great Debates in Hematologic Malignancies? The people. Conversations in the hallways, shared insights over coffee, and clinicians from all backgrounds coming together to challenge perspectives. Scroll through for a look at the moments and the